Filter Results:
(694)
Show Results For
- All HBS Web
(1,025)
- News (154)
- Research (694)
- Events (23)
- Multimedia (1)
- Faculty Publications (440)
Show Results For
- All HBS Web
(1,025)
- News (154)
- Research (694)
- Events (23)
- Multimedia (1)
- Faculty Publications (440)
Sort by
- 27 Jan 2015
- First Look
First Look: January 27
case: https://cb.hbsp.harvard.edu/cbmp/product/213078-PDF-ENG Harvard Business School Case 815-061 Samuel Colt: An American Gun Maker Samuel Colt not only perfected and patented the technology for a gun that could fire multiple times... View Details
Keywords: Sean Silverthorne
- 23 Oct 2012
- First Look
First Look: October 23
Publication:Management Science (forthcoming) Abstract This paper studies the impact that immigrant innovators have on the global activities of U.S. firms by analyzing detailed data on patent applications and on the operations of the... View Details
Keywords: Sean Silverthorne
- April 2024 (Revised July 2024)
- Case
Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs
By: Joseph L. Badaracco, Tom Quinn and John Schultz
Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of... View Details
Keywords: Cost vs Benefits; Decisions; Judgments; Values and Beliefs; Global Strategy; Health Care and Treatment; Patents; Growth and Development Strategy; Growth Management; Product Positioning; Supply and Industry; Supply Chain; Corporate Social Responsibility and Impact; Mission and Purpose; Philanthropy and Charitable Giving; Opportunities; Social Issues; Equality and Inequality; Pharmaceutical Industry; Health Industry; Denmark; United States; Europe; China; India; Middle East; North Africa
Badaracco, Joseph L., Tom Quinn, and John Schultz. "Market Dynamics and Moral Dilemmas: Novo Nordisk’s Weight-Loss Drugs." Harvard Business School Case 324-114, April 2024. (Revised July 2024.)
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
firms face little competition, even after the end of formal periods of patent protection and market exclusivity. Additionally, the evolving technologies of drug development—in particular, the increasingly common use of auxiliary endpoints... View Details
Keywords: Dina Gerdeman
- 05 Aug 2014
- First Look
First Look: August 5
count, patent count, and publication count, as well as their citations and the collaborative nature between funded and unfunded firms. Because randomization of the sample was not feasible, we address endogeneity around selection bias... View Details
Keywords: Sean Silverthorne
- 07 Nov 2006
- First Look
First Look: November 7, 2006
with one another to innovate? To answer this question, the authors compiled a dataset identifying all coauthorship relationships of U.S. patent inventors from 1975 through 1999. That dataset revealed that the social network of innovators... View Details
Keywords: Sean Silverthorne
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
significant patent suit with Amgen. The deal nonetheless provided access to one of the most successful integrated learning bases in the new technology.30 This same lack of technical capabilities on the part of American Home Products... View Details
- 26 Jan 2004
- Research & Ideas
What Developing-World Companies Teach Us About Innovation
software, consumer electronics, and pharmaceuticals. Such companies hold many important patents and boast R&D labs that rival facilities at the best universities in the world. They are headquartered in countries with myriad... View Details
- 22 Jan 2019
- First Look
New Research and Ideas, January 22, 2019
majority of patents (especially in manufacturing). We also offer evidence that the suppliers’ conceptual attributes are higher for SC industries, which is consistent with their greater innovative activity. Finally, we find that employment... View Details
Keywords: Dina Gerdeman
- 17 Oct 2006
- First Look
First Look: October 17, 2006
by universities on sharing rather than patenting scientific discoveries; more cross-disciplinary academic research; and more federal and private funding for translational research, which bridges basic and applied science. With such... View Details
Keywords: Sean Silverthorne
- 07 Dec 2010
- First Look
First Look: Dec. 7
case:http://cb.hbsp.harvard.edu/cb/product/711417-PDF-ENG Plavix: Drugs in the Age of Personalized Medicine Richard G. Hamermesh, Mara G. Aspinall, and Rachel GordonHarvard Business School Note 811-001 PIavix, one of the world's best selling drugs in 2010, appears to... View Details
Keywords: Sean Silverthorne
- 29 Sep 2009
- First Look
First Look: September 29
inventions as the top 1% of U.S. inventions for a technology during 1975-1984 in terms of subsequent citations. Patenting growth is significantly higher in cities and technologies where breakthrough inventions occur after 1984 relative to... View Details
Keywords: Martha Lagace
- 23 Jun 2015
- First Look
First Look: June 23, 2015
and patenting data for 1,315 employees at the Indian R&D center of a Fortune 500 technology firm, I exploit a natural experiment where the assignment of managers for newly hired college graduates is mandated by rigid HR rules and is... View Details
Keywords: Sean Silverthorne
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
World War I, it was allowed to share patents with AT&T, Westinghouse, and United Fruit, which used radio to communicate across its infrastructure of plantations and transportation links throughout Latin America. LR: What lies ahead... View Details
Keywords: by Jim Aisner
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and testing. With health benefits globally from the availability of new drugs, albeit for poorer... View Details
Keywords: Sean Silverthorne
- 13 Feb 2018
- First Look
New Research and Ideas, February 13, 2018
backlogs and delays in numerous Patent and Trademarks Offices, and litigation over IP rights is expensive with an uncertain outcome. Moreover, local governments can succeed in transferring value to local firms and influencing global... View Details
Keywords: Sean Silverthorne
- 13 Nov 2012
- First Look
First Look: November 13
Importantly, these past track records also predict divergent future real outcomes in patents, patent citations, and new product innovations. Read the paper: http://www.people.hbs.edu/lcohen/pdffiles/dimalco.pdf Paying It Forward:... View Details
Keywords: Sean Silverthorne
- 17 Jan 2017
- First Look
First Look at New Research: January 17
migration databases, to the legal codification of national policies regarding high-skilled migration, to the analysis of patent data regarding cross-border inventor movements. A common theme throughout this research is the importance of... View Details
Keywords: Sean Silverthorne